Plasma Fractionation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Plasma Fractionation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • August 2018 •
  • 194 pages •
  • Report ID: 5586923 •
  • Format: PDF
Global Plasma Fractionation Market - Overview

Rising demand for plasma proteins, increasing investment in innovation and rising prevalence of rare diseases across the world are major factors that are expected to propel the global plasma fractionation market. The global market has been segmented based on product type, application, end-user, and region.

The global plasma fractionation market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.

This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the plasma fractionation market.

Global Plasma Fractionation Market: Key Segments
The global plasma fractionation market has been segmented based on product type, application, end-user and region.In terms of product type, the global plasma fractionation market has been classified into immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors, and other plasma products.

The immunoglobulin segment has been further sub-segmented into intravenous immunoglobulin and subcutaneous immunoglobulin.The coagulation factor concentrates segment factor VIII, factor IX, factor XIII, prothrombin complex concentrate, Von Willebrand factor and fibrinogen concentrates.

The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of application, the global plasma fractionation market has been segregated into neurology, immunology, hematology, critical care, pulmonology, and other applications. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of end-user, the global market has been classified into hospitals and clinics, clinical research laboratories, and academic institutes.The segments have been analyzed based on health care infrastructure, government investment, and economic development in the regions.

The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Plasma Fractionation Market: Regional Outlook
In terms of region, the global plasma fractionation market has been segmented into five major regions and the key countries in the respective region are: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Mexico, Brazil, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report
The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.Major players operating in the global plasma fractionation market include .

These players are adopting organic and inorganic growth strategies in order to expand product offerings, strengthen geographical reach, increase customer base, and garner market share.

The global plasma fractionation market has been segmented as follows:

Global Plasma Fractionation Market, by Product Type
Immunoglobulin
Intravenous Immunoglobulin
Subcutaneous Immunoglobulin
Coagulation Factor Concentrates
Factor VIII
Factor IX
Factor XIII
Prothrombin Complex Concentrates
Von Willebrand Factor (VWF)
Fibrinogen Concentrates
Albumin
Protease Inhibitors
Other Plasma Products

Global Plasma Fractionation Market, by Application
Neurology
Immunology
Hematology
Critical Care
Pulmonology
Other Applications

Global Plasma Fractionation Market, by End-user
Hospitals and Clinics
Clinical Research Laboratories
Academic Institutes

Global Plasma Fractionation Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
Japan
China
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa